FDA
-
-
-
-
-
-
-
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Ionis shares significant business and pipeline progress at Innovation Day, highlighting strength of capabilities from research and technology through commercialization
-
-
-
-
-
-
-
Bicycle Therapeutics Plc (BCYC) Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

